Literature DB >> 2326458

Lung cancer in patients seropositive for human immunodeficiency virus.

M A Braun1, D A Killam, S C Remick, J C Ruckdeschel.   

Abstract

The authors describe the clinical and radiographic findings of lung carcinoma in six patients infected with the human immunodeficiency virus (HIV). These patients were in a younger age group than is commonly associated with lung cancer. The radiographic findings included mediastinal adenopathy (n = 5), hilar masses with distal atelectasis (n = 3), parenchymal masses (n = 3), pleural effusions (n = 2), and pleural thickening (n = 1). Recognition of any of these findings should raise the diagnostic possibility of lung cancer in this group of younger patients.

Entities:  

Mesh:

Year:  1990        PMID: 2326458     DOI: 10.1148/radiology.175.2.2326458

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

Review 1.  Management of patients with HIV in the intensive care unit.

Authors:  Henry Masur
Journal:  Proc Am Thorac Soc       Date:  2006

Review 2.  AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

Review 3.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 4.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Anthony J Alberg; Malcolm V Brock; Jean G Ford; Jonathan M Samet; Simon D Spivack
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

5.  Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: a prospective, cohort study.

Authors:  B Afessa
Journal:  BMC Pulm Med       Date:  2001       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.